Wow, MSB really leading the way (joke):Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)
December 6, 2021
- HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per year
- Orphan Drug Designation confers certain benefits and may result in seven year market exclusivity upon approval for this indication if all statutory and regulatory requirements are met
- Supplements Rare Pediatric Disease Designation recently granted by FDA
MIAMI, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect in infants.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-76
-
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
95.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 95.0¢ | $329.8K | 345.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 174779 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.5¢ | 33729 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 163353 | 0.950 |
14 | 98172 | 0.945 |
17 | 107932 | 0.940 |
10 | 156690 | 0.935 |
13 | 469452 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 31384 | 18 |
0.960 | 68134 | 11 |
0.965 | 25198 | 8 |
0.970 | 84582 | 7 |
0.975 | 134143 | 6 |
Last trade - 10.43am 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |